Leaflet DOXIPROCT 40mg / 20mg / g rectal ointment

Indicated for: haemorrhoids; anorectal pain and itching

Route of administration: rectal

Substance: calcium dobesylate + lidocaine (capillary vasoprotector + local anesthetic)

ATC: C05AD01 (Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Local anesthetics)

Precautions:
Avoid milk, calcium, iron, or antacids
Avoid milk, calcium, iron, or antacids

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

The combination of calcium dobesilate and lidocaine is used for the symptomatic treatment of hemorrhoids and other anorectal conditions associated with inflammation and pain. Calcium dobesilate has vasoprotective and anti-inflammatory effects, reducing capillary permeability and improving microcirculation, while lidocaine is a local anesthetic that provides rapid pain and discomfort relief.

The medication is available as creams, ointments, or suppositories and is applied locally, as directed by a doctor. The frequency of application and duration of treatment are adjusted based on the severity of symptoms.

Common side effects include local irritation, burning sensation, or itching. In rare cases, severe allergic reactions or increased sensitivity to lidocaine may occur.

This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are using to avoid drug interactions. Additionally, it is important for patients to follow application instructions to prevent adverse effects.

General data about DOXIPROCT 40mg / 20mg / g

  • Substance: calcium dobesylate + lidocaine
  • Date of latest medicines list: 01-06-2026
  • Product code: W54548001
  • Concentration: 40mg / 20mg / g
  • Pharmaceutical form: rectal ointment
  • Quantity: 1
  • Product type: Original
  • Price: 28.31 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: OM PHARMA S.A. - PORTUGALIA
  • Holder: OM PHARMA S.A. - PORTUGALIA
  • Number: 9505/2016/01
  • Shelf life: 5 years

Combinations with other substances

Compensation lists for DOXIPROCT 40mg / 20mg / g Om Pharma

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

28.31 RON

28.31 RON

0.00 RON